SCHEMBL7863185

SCHEMBL7863185

CC(CC(=O)O)c1cccc(CNC(=O)c2cccc(Nc3nc4ccccc4[nH]3)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.56
ITGB3 P05106 7/20 0.54
ITGAV P06756 7/20 0.54
HTT P42858 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
MEN1 O00255 2/20 0.47
MAPT P10636 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
HDAC6 Q9UBN7 2/20 0.45
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
LMNA P02545 2/20 0.44
RXFP1 Q9HBX9 1/20 0.44
HDAC11 Q96DB2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8524765 0.92 AKR1C3 (0.54) AKR1C3ITGB3ITGAVHTTSMN1; SMN2
SCHEMBL8526841 0.90 AKR1C3 (0.54) AKR1C3ITGB3ITGAVHTTSMN1; SMN2
SCHEMBL7863112 0.89 ROCK1 (0.47) AKR1C3ITGB3ITGAVHTTSMN1; SMN2
SCHEMBL8524766 0.86 AKR1C3 (0.58) AKR1C3ITGB3ITGAVHTTSMN1; SMN2
SCHEMBL8534047 0.85 AKR1C3 (0.57) AKR1C3ITGB3ITGAVHTTSMN1; SMN2
SCHEMBL8525720 0.81 HDAC11 (0.44) AKR1C3ITGB3ITGAVSMN1; SMN2NPC1
SCHEMBL8526505 0.79 ROCK1 (0.46) AKR1C3HTTSMN1; SMN2NPC1RAB9A
SCHEMBL7861566 0.77 ROCK2 (0.41) ITGB3ITGAV
SCHEMBL8534053 0.76 HDAC11 (0.45) AKR1C3ITGB3ITGAVHTTSMN1; SMN2
SCHEMBL8525722 0.75 HDAC11 (0.46) AKR1C3ITGB3ITGAVSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0889877-B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS SEARLE & CO (US) 2001-08-29 EP claimed
EP-0889877-A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS G.D. SEARLE & CO. (US) 1999-01-13 EP claimed
WO-1997036862-A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS G.D. SEARLE & CO. (US) 1997-10-09 WO claimed
EP-0889877-B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS SEARLE & CO (US) 2001-08-29 EP disclosed